title: Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML).
authors.forename: M M
authors.initials: MM
authors.lastname: van den Heuvel-Eibrink
authors.forename: E A
authors.initials: EA
authors.lastname: Wiemer
authors.forename: M
authors.initials: M
authors.lastname: Kuijpers
authors.forename: R
authors.initials: R
authors.lastname: Pieters
authors.forename: P
authors.initials: P
authors.lastname: Sonneveld
mesh_terms: D003561:Cytarabine / Q000378:metabolism / Q000627:therapeutic use; D003842:Deoxycytidine Kinase / Q000235:genetics*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics*; D009154:Mutation; D012008:Recurrence
chemical_list: D003561:Cytarabine; D003842:Deoxycytidine Kinase